You searched for: sensitization
Increased bids for Sensidose
The takeover bids for Sensidose continue to increase and the valuation has now reached SEK 100 million. At the end of last week, EQL announced...
Life science business rate gives hope for recovery
The major pharmaceutical companies have opened their wallets at the beginning of 2023 – at least when compared to the previous year. The business volume...
New takeover bid for Sensidose
Parkinson's disease company Sensidose is emerging as a hot acquisition candidate in the life sciences sector. In March, BioStock reported that Norwegian Navamedic...
Sensidose's share rises after bid from Navamedic
Sensidose develops and sells individualized dosing of drugs for the medical treatment of Parkinson's disease. The pharmaceutical company is in a...
Sensidose is growing and seeing new opportunities in Finland
Pharmaceutical company Sensidose is growing and seeing new opportunities in new markets. According to yesterday's year-end report, sales increased by 10,9 percent in existing...
Sensidose's vice president in 100 days on the job
Philip Slätis
Sensidose declines in Q3 but expects sales growth
Spotlight-listed Sensidose reports progress on several fronts in the third quarter, despite component shortages and some other challenges. During the quarter,...
Congress in Poland paves the way for Sensidose
Sensidose recently participated in the Polish Neurological Society's annual scientific and educational conference in Lublin. An increased presence is a strategic step...
Sensidose's founder talks about the company's journey
The idea for the Sensidose treatment strategy came about in the mid-1990s when professors Sten-Magnus Aquilonius and Christer Nyström realized...
Sensidose recruits vice president ahead of expansion
Pharmaceutical company Sensidose has recruited Philip Slätis as Chief Operating Officer and Vice President, effective November 1. With broad...
Continued positive sales development for Sensidose
Sensidose recently published its second quarter report, reporting a 21 percent sales increase compared to the same quarter in 2021....
Sensidose's CEO looks to the fall after strong growth
Sensidose enters the first half of the year with strong cash flow after listing on Spotlight and rising sales despite component shortages. In addition,...